BC Cancer Agency Home

What's New               Monday, March 30, 2015

BC Cancer Agency’s POG Program leads to a unique breakthrough in a patient’s treatment

The Personalized Onco-Genomics (POG) Program at the BC Cancer Agency has identified a life-altering treatment option for a patient with advanced cancer.

POG has given Trish Keating a new reason to hope as the genomic sequencing of her aggressive colorectal cancer identified a unique protein function at play. This critical detail pointed to an outside-of-the-box treatment option, which has dramatically reduced her cancer to barely detectable in just weeks. More...

Additional POG information for patients:

What is POG? The BC Cancer Agency’s Personalized Onco-Genomics (POG) program is a clinical research initiative that’s embedding genomic sequencing into real-time treatment planning for patients with incurable cancers.

What are the main goals of POG? The Program is setting out to decode the genome — the entire DNA inside the cell— of each patient’s cancer, to understand what is enabling it to grow and to develop treatment strategies to block its growth.

Who is eligible for POG? This research Program is for cancer patients being treated at the BC Cancer Agency (BC residents only) with metastatic disease.

Who do I contact for more information on POG? For more information on POG and eligibility, patients should speak to their medical oncologist.

How do patients get enrolled in POG?Patients should discuss their clinical treatment options, including clinical trials and POG with their oncologist.

Website upgrade coming for the BC Cancer Agency

The BC Cancer Agency will launch an updated website with a new design in March. It will be easier to read and navigate so our patients and families, colleagues, donors and partners can access the information they are looking for. This new website is also mobile-friendly, meaning that it’s easily viewed from smartphones and tablets – great news for our very mobile world! More...

 
Researchers at the BC Cancer Agency part of global initiative to understand the human “epigenome”

Research from the BC Cancer Agency is featured today in the prestigious journal Nature as part of a special issue highlighting 20 papers that are the outcome of a seven year project mapping the epigenome.

The project called, The National Institutes of Health (NIH) Roadmap Epigenomics Program, provides a core set of data, methodology and infrastructure for studying the role of the epigenome in human health and disease. The original goal was to map 25 normal reference epigenomes, but new technology allowed the team to produce 111 highly detailed maps on how the epigenome varies and operates in different settings. More...

HONcode accreditation seal. We comply with the HONcode standard for health trust worthy information:verify here.

Our Locations


Abbotsford

32900 Marshall Road
Abbotsford, BC V2S 0C2
604.851.4710
1.877.547.3777 (in BC and Yukon)


Centre for the North
1215 Lethbridge Street
Prince George, BC V2N 7E9
250.645.7300
1.855.775.7300 (in BC and Yukon)


Fraser Valley
13750 96th Avenue
Surrey, BC V3V 1Z2
604.930.2098
1.800.523.2885 (in BC and Yukon)


Southern Interior
399 Royal Avenue
Kelowna, BC V1Y 5L3
250.712.3900
1.888.563.7773 (in BC and Yukon)


Vancouver
600 West 10th Avenue
Vancouver, BC V5Z 4E6
604.877.6000
1.800.663.3333 (in BC and Yukon)
 
Vancouver Island
2410 Lee Avenue
Victoria, BC  V8R 6V5
250.519.5500
1.800.670.3322 (in BC and Yukon)


BC Cancer Foundation
150 - 686 W. Broadway
Vancouver, BC V5Z 1G1
604.877.6040
604.877.6161 (fax)
1.888.906.CURE/2873 (in BC)

BC Cancer Agency Research Centre
675 West 10th Avenue
Vancouver, BC V5Z 1L3
604.675.8000
1.888.675.8001 (in BC and Yukon)

Executive and
Provincial Offices

600 West 10th Avenue
Vancouver, BC V5Z 4E6
604.877.6000